Go Back
Xencor Inc reports $60.7 million Q1 loss
By USInMinutes - May 08, 2023, 05:33 PM ET
Last Updated - Jul 18, 2023, 03:34 PM EDT
The company generated $18.90 million in quarterly revenue
Xencor Inc [XNCR] has reported fiscal Q1 loss of $60.70 million.
On a per-share basis, the DE based company said its diluted earnings are $1.02.
The Pharmaceutical Preparations firm posted revenue of $18.90 million in this period.
Also Read:
- Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023
- Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
- Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023
- Xencor Presents Data from Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin Lymphoma at the American Society of Hematology Annual Meeting
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News